Engineers Gate Manager’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$866K Sell
40,145
-58,759
-59% -$1.27M 0.01% 1192
2025
Q1
$1.64M Sell
98,904
-1,044
-1% -$17.3K 0.03% 784
2024
Q4
$1.83M Sell
99,948
-33,246
-25% -$610K 0.03% 665
2024
Q3
$2.05M Buy
133,194
+25,449
+24% +$391K 0.04% 645
2024
Q2
$1.75M Sell
107,745
-96,928
-47% -$1.58M 0.04% 616
2024
Q1
$3.78M Buy
+204,673
New +$3.78M 0.1% 265
2023
Q4
Sell
-142,241
Closed -$2.96M 1935
2023
Q3
$2.96M Buy
142,241
+76,880
+118% +$1.6M 0.11% 241
2023
Q2
$1.57M Sell
65,361
-11,249
-15% -$269K 0.06% 455
2023
Q1
$1.44M Buy
76,610
+57,530
+302% +$1.08M 0.06% 430
2022
Q4
$304K Sell
19,080
-16,175
-46% -$258K 0.02% 1179
2022
Q3
$577K Buy
35,255
+2,568
+8% +$42K 0.04% 705
2022
Q2
$461K Buy
+32,687
New +$461K 0.02% 1154
2022
Q1
Sell
-24,319
Closed -$568K 1791
2021
Q4
$568K Buy
+24,319
New +$568K 0.03% 966
2021
Q3
Sell
-11,030
Closed -$269K 1590
2021
Q2
$269K Sell
11,030
-29,845
-73% -$728K 0.02% 1204
2021
Q1
$1.06M Buy
40,875
+32,425
+384% +$837K 0.05% 565
2020
Q4
$452K Sell
8,450
-41,790
-83% -$2.24M 0.02% 1040
2020
Q3
$2.07M Buy
50,240
+33,688
+204% +$1.39M 0.1% 286
2020
Q2
$802K Buy
+16,552
New +$802K 0.04% 699
2020
Q1
Sell
-18,151
Closed -$776K 1525
2019
Q4
$776K Buy
+18,151
New +$776K 0.03% 775
2019
Q3
Sell
-22,550
Closed -$603K 1342
2019
Q2
$603K Buy
+22,550
New +$603K 0.03% 658